(Q37686732)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Immunoadsorption for systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

17 January 2020

main subject

0 references

author

Kurt Derfler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Martin Aringer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

G H Stummvoll

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

U Julius

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

Atherosclerosis. Supplements

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

110-113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Association of IgG Anti-Brain Antibodies with Central Nervous System Dysfunction in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Dyspnoea in a young woman with active systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

[Respiratory involvement in systemic lupus erythematosus]

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Severe infections in plasmapheresis-treated systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Immunoadsorption and plasma exchange in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Immunoadsorption and CD20 antibody treatment in a patient with treatment resistant systemic lupus erythematosus and preterminal renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Cyclophosphamide and immunoadsorption apheresis treatment of lupus nephritis nonresponsive to drug therapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Immunoadsorbent apheresis eliminates pathogenic IgG in childhood lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5688%2809%2971823-9

7 January 2021

10.1016/S1567-5688(09)71823-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129387%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference